Treatment of Pemphigus Vulgaris and Pemphigus Foliaceus: A Systematic Review and Meta-Analysis

Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study

(2014) A.J. Kanwar et al.   BRITISH JOURNAL OF DERMATOLOGY

Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial

(2014) Ladan Dastgheib et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Durable Remission of Pemphigus With a Fixed-Dose Rituximab Protocol

(2014) Kara Heelan et al.   JAMA Dermatology

Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris

(2013) V. K. Sharma et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: A preliminary prospective randomized controlled study

(2012) AmrinderJ Kanwar et al.   Indian Journal of Dermatology Venereology & Leprology

Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients

(2012) Yael A. Leshem et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study

(2011) D. Ioannides et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Treating Pemphigus Vulgaris with Prednisone and Mycophenolate Mofetil: A Multicenter, Randomized, Placebo-Controlled Trial

(2010) Stefan Beissert et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris

(2009) Sujay Khandpur et al.   Indian Journal of Dermatology Venereology & Leprology

A randomized double-blind trial of intravenous immunoglobulin for pemphigus

(2009) Masayuki Amagai et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Multicenter Randomized, Double-blind, Placebo-Controlled, Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance-Phase Pemphigus Vulgaris

(2008) Victoria P. Werth et al.   ARCHIVES OF DERMATOLOGY

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

(2008) Dedee F. Murrell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY